Merck & Co.: Difference between revisions
No edit summary |
|||
Line 1: | Line 1: | ||
{{Short description|American multinational pharmaceutical company}} | {{Short description|American multinational pharmaceutical company}} | ||
{{Infobox company | {{Infobox company | ||
| name = Merck & Co., Inc. | | name = Merck & Co., Inc. | ||
| logo = [[File:Merck Logo.svg|200px]]<br>[[File:MSD Sharp & Dohme GmbH logo.svg|155px]] | | logo = [[File:Merck Logo.svg|200px]]<br>[[File:MSD Sharp & Dohme GmbH logo.svg|155px]] | ||
| image = Merck office Upper Gwynedd Township Montgomery County.jpg | | image = Merck office Upper Gwynedd Township Montgomery County.jpg | ||
| image_caption = | | image_caption = [[:en:Upper Gwynedd Township, Montgomery County, Pennsylvania|アッパー・グウィネッド・タウンシップ]], [[:en:Pennsylvania|ペンシルバニア州]]にあるMerck's branch office campus | ||
| logo_caption = | | logo_caption = 1992年に[[:en:Chermayeff & Geismar & Haviv|Chermayeff & Geismar]]のSteff Geissbuhlerがデザインした現在のメルク・アンド・カンパニーのロゴ。米国とカナダでは "MERCK"の商号が使用され(上)、これらの国以外では "MSD"が使用されている(下)。 | ||
| logo_size = | | logo_size = | ||
| type = [[Public company|Public]] | | type = [[:en:Public company|Public]] | ||
| traded_as = {{ubl|{{NYSE|MRK}}| | | traded_as = {{ubl|{{NYSE|MRK}}|{{DJIA component}}|{{S&P 100 component}}|{{S&P 500 component}}}} | ||
| industry = [[Pharmaceutical industry]] | | industry = [[:en:Pharmaceutical industry|Pharmaceutical industry]] | ||
| founders = {{ubl|Theodore Weicker|George Merck}} | | founders = {{ubl|Theodore Weicker|George Merck}} | ||
| foundation = {{ubl | | foundation = {{ubl | ||
|{{Start date and age|1891|1}}, | |{{Start date and age|1891|1}}, [[:en:Merck Group|Merck]]の子会社として | ||
|{{start date and age|1917}}, | |{{start date and age|1917}}, 独立会社として | ||
}} | }} | ||
| location = [[Rahway, New Jersey]], | | location = [[Wikipedia:Rahway, New Jersey|Rahway, New Jersey]], {{Country|アメリカ}} | ||
| area_served = Worldwide | | area_served = Worldwide | ||
| key_people = Robert M. Davis {{nowrap|(chairman, president and CEO)}} | | key_people = Robert M. Davis {{nowrap|(chairman, president and CEO)}} | ||
| products = {{hlist|[[Pharmaceutical]] | | products = {{hlist|[[Pharmaceutical/ja|Pharmaceutical]]|[[generic drug/ja]]|[[over-the-counter drug/ja]]|[[vaccine/ja]]|[[Medical diagnosis/ja|diagnostics]]|[[contact lens/ja]]|[[Veterinary medicine/ja]]}} | ||
| revenue = {{Increase}} {{US$|60.12 billion|link=yes}} (2023) | | revenue = {{Increase}} {{US$|60.12 billion|link=yes}} (2023) | ||
| operating_income = {{Decrease}} US$1.889 billion (2023) | | operating_income = {{Decrease}} US$1.889 billion (2023) |